The Actions of Dopamine on the Blood Pressure and Heart Rate of Conscious Hypertensive Rats: Evidence for Reduced Dopaminergic Activity in Rats of the Japanese Strains

References

• Kondo K., Ebihara A., Suzuki H., Saruta T. Role of dopamine in the regulation of blood pressure and the renin-angiotensin-aldosterone system in conscious rats. Clin. Sci. 1981; 61: 235s–237s
   PubMed Web of Science ®Google Scholar
• Kondo K., Suzuki H., Handa M., Nagahama S., Saruta T. Effects of intracerebroventricular administration of dopamine and metoclopramide on blood pressure in rats. Arch. Int. Pharmacodyn. Ther. 1981; 250: 273–278
   PubMedGoogle Scholar
• Kawabe H., Kondo K., Saruta T. Effects of the intracerebroventricular injection of dopamine on blood pressure in the spontaneously hypertensive rat. Clin. Exp. Hypertens. 1983; 5(10)1703–1716
   Web of Science ®Google Scholar
• Stumpe K. O., Kolloch R., Higuchi M., Kruck F., Vetter H. Hyperprolactinaemia and antihypertensive effect of bromocriptine in essential hypertension: identification of abnormal central dopamine control. Lancet 1977; 2: 211–214
   PubMed Web of Science ®Google Scholar
• Kolloch R. E., Stump K. O., Ismer U., Kletzky O., DeQuattro V. Central dopaminergic mechanisms in young patients with essential hypertension. Clin. Sci. 1981; 61: 231s–234s
   PubMed Web of Science ®Google Scholar
• McMurty J. P., Kazama N., Wexler B. C. Effects of bromocriptine on hormone and blood pressure levels in spontaneously hypertensive rats. Proc. Soc. Exp. Biol. Med. 1979; 161: 186–188
   PubMed Web of Science ®Google Scholar
• Hutchinson J. S., DiNicolantonio R., Lim A., Clements J., Funder J. W. Effects of bromocriptine on blood pressure and plasma β-endorphin in spontaneously hypertensive rats. Clin. Sci. 1981; 61: 343s–345s
   PubMed Web of Science ®Google Scholar
• Hutchinson J. S., Mok J. S.L. Neuropeptide abnormalities suggest a dopaminergic basis for high blood pressure in the spontaneously hypertensive rats. Clin. Exp. Hypertens. 1984; 6(10 & 11)2055–2058
   Web of Science ®Google Scholar
• DeVito W. J., Sutterer J. R., Brush R. F. The pituitary-adrenal response to ether stress in the spontaneously hypertensive and normotensive rat. Life Sci. 1981; 28: 1489–1495
   PubMed Web of Science ®Google Scholar
• Weeks J. R., Jones J. A. Routine direct measurement of arterial pressure in unanesthetized rats. Proc. Soc. Exp. Biol. Med. 1960; 104: 646–650
   PubMed Web of Science ®Google Scholar
• SAS Institute Inc. SAS User's Guide Statistic, Version 5 Edition. Cary, NC 1985; 113–138
   Google Scholar
• Baum T., Shropshire A. T. Reduction of sympathetic outflow by central administration of L-DOPA, dopamine and norepinephrine. Neuropharmacology 1973; 12: 49–56
   PubMed Web of Science ®Google Scholar
• Heise A., Kroneberg G. Central nervous α-adrenergic receptors and the mode of action of α- methyldopa. Naunyn-Schmiedebergs Arch. Pharmacol. 1973; 279: 285–300
   PubMed Web of Science ®Google Scholar
• Heise A. Hypotensive action of central α-adrenergic and dopaminergic receptor stimulation. New antihypertensive Drugs, A. Scriabine, C. S. Sweet. Spectrum Publications, New York 1976; 135–145
   Google Scholar
• Day M. D., Roach A. G. Cardiovascular effects of dopamine after central administration into conscious cats. Br. J. Pharmacol. 1976; 58: 505–515
   PubMed Web of Science ®Google Scholar
• McCubbin J. W., Kaneko Y., Page I. H. Ability of serotonin and norepinephrine to mimic the central effects of reserpine on vasomotor activity. Cir. Res. 1960; 8: 849–858
   PubMed Web of Science ®Google Scholar
• Lang W. J., Woodman O. L. Cardiovascular responses produced by the injection of dopamine into the cerebral ventricles of the anaesthetized dog. Br. J. Pharmacol. 1979; 66: 235–240
   PubMed Web of Science ®Google Scholar
• Takata Y., Hutchinson J. S. Leakage of angiotensin converting enzyme inhibitors from the cerebral ventricles into the peripheral circulation in conscious, spontaneously hypertensive rats. Methods Find. Exp. Clin. Pharmacol. 1983; 5: 139–142
   PubMed Web of Science ®Google Scholar
• Nagahama S., Chen Y- F., Oparil S. Mechanism of the depressor effects of bromocriptine in the spontaneously hypertensive rat. J. Pharmacol. Exp. Ther. 1984; 228: 370–375
   PubMed Web of Science ®Google Scholar
• Judy W. V., Watanabe A. M., Henry D. P., Besch H. R., Jr., Murphy W. R., Hockel G. M. Sympathetic nerve activity: Role in regulation of blood pressure in the spontaneously hypertensive rat. Circ. Res. 1976; 38: II-21–II-29
   Web of Science ®Google Scholar
• Sapru H. N., Wang S. C. Modification of aortic baroreceptor resetting in the spontaneously hypertensive rat. Am. J. Physiol. 1976; 230: 664–674
   PubMed Web of Science ®Google Scholar
• Yazaki Y., Ohuchi Y., Ashida T., Tsai R- C. Vasopressin as a possible contributor to hypertension. Jpn. Circ. J. 1984; 48: 188–195
   PubMedGoogle Scholar
• Hutchinson J. S., Mendelsohn F. A.O., Csicsmann J., DiNicolantonio R., Takata Y., Doyle A. E. Brain angiotensin converting enzyme, plasma beta-endorphin and thyrotropin in New Zealand and Japanese genetically hypertensive rats. Exp. Brain Res. 1982, Suppl 4: 148–154
   PubMed Web of Science ®Google Scholar
• Hutchinson J. S., DiNicolantonio R., Takata Y., Veroni M., Jerums G., Doyle A. E. Comparison of neuroendocrine factors in Japanese and New Zealand strains of hypertensive rats. Endocrinology of Hypertension, F. Mantero, E. G. Biglieri, C. R.W. Edwards. Academic press, London and New York 1982; 404–407
   Google Scholar
• Okamoto K. Spontaneously hypertension in rats. Int. Rev. Exp. Pathol. 1969; 7: 227–270
   PubMedGoogle Scholar
• Fuxe K., Ganten D., Jonsson G., Bolme P., Agnati L. F., Andersson K., Goldstein M., Hokfelt T. Evidence for a selective reduction of adrenaline turnover in the dorsal midline area of the caudal medulla oblongata of young spontaneously hypertensive rats. Acta Physiol. Scand. 1979; 107: 397–399
   PubMedGoogle Scholar
• Fuxe K., Ganten D., Jonsson G., Agnati L. F., Andersson K., Hokfelt T., Bolme P., Goldstein M., Hallman H., Unger T., Rascher W. Catecholamine turnover changes in hypothalamus and medulla oblongata of spontaneously hypertensive rats. Neurosci. Lett. 1979; 15: 283–288
   PubMed Web of Science ®Google Scholar
• Kuschinsky R, Bell C. Neural and non-neural components of the developing hypertension in genetically hypertensive rats. J. Auton. Nerv. Syst. 1983; 7: 141–148
   PubMedGoogle Scholar
• Vanhoutte P. M., Webb R. C., Collis M. G. Pre- and post-junctional adrenergic mechanisms and hypertension. Clin. Sci. 1980; 59: 211s–223s
   PubMed Web of Science ®Google Scholar
• Antonaccio M. J., Rubin B., Horovitz Z. P. Effects of captopril in animal models of hypertension. Clin. Exp. Hypertens. 1980; 2: 613–637
   PubMed Web of Science ®Google Scholar
• Antonaccio M. J., Ferrone R. A., Waugh M., Harris D., Rubin B. Sympathoadrenal and renin-angiotensin systems in the development of two-kidney, one clip renal hypertension in rats. Hypertension 1980; 2: 723–731
   PubMed Web of Science ®Google Scholar
• Judy W. V., Watanabe A. M., Henry D. P., Besch H. R., Jr., Aprison B. Effect of 1-dopa on sympathetic nerve activity and blood pressure in the spontaneously hypertensive rat. Cir. Res. 1978; 43: 24–28
   PubMed Web of Science ®Google Scholar
• Phelan E. L., Simpson F. O., Smirk F. H. Characteristics of the New Zealand strain of genetically hypertensive (GH) rats. Clin. Exp. Pharmacol. Physiol. 1976, Suppl 3: 546–550
   Google Scholar
• Hutchinson J. S., Mendelsohn F. A.O., Doyle A. E. Blood pressure response of conscious normotensive and spontaneously hypertensive rats to intracerebroventricular and peripheral administration of captopril. Hypertension. 1980; 2: 546–550
   PubMed Web of Science ®Google Scholar